Article Text

PDF

Cis-platinum chemotherapy for ocular basal cell carcinoma.
  1. M. Morley,
  2. P. T. Finger,
  3. M. Perlin,
  4. L. R. Weiselberg and
  5. D. S. DeBlasio
  1. Department of Ophthalmology, Manhattan Eye, Ear, and Throat Hospital, New York City.

    Abstract

    We have used intravenous cis-platinum chemotherapy in the treatment of three patients with basal cell carcinoma of the lid extending into the orbit. Cis-platinum chemotherapy caused a reduction in tumour size and thereby delayed surgery in all cases. It allowed for local resection in one case, appeared to delay a patient's exenteration in a second case, and was used prior to radiotherapy in a third case. While not curative, cis-platinum may be useful as an adjuvant to decrease tumour mass prior to local excision and for patients who refuse or must delay exenteration.

    Statistics from Altmetric.com

    Request permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.